GILD
$123.19
Revenue | $7769Mn |
Net Profits | $3052Mn |
Net Profit Margins | 39.28% |
Gilead Sciences Inc.’s revenue jumped 2.97% since last year same period to $7769Mn in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 9.72% jump in its revenue since last 3-months.
Gilead Sciences Inc.’s net profit jumped 143.58% since last year same period to $3052Mn in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 55.71% jump in its net profits since last 3-months.
Gilead Sciences Inc.’s net profit margin jumped 136.55% since last year same period to 39.28% in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 41.92% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.16 |
EPS Estimate Current Year | 2.16 |
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.16 - a 10.2% jump from last quarter’s estimates.
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 2.16.
Earning Per Share (EPS) | 2.47 |
Dividend Per Share (DPS) | 0.79 |
Gilead Sciences Inc.’s earning per share (EPS) jumped 22.28% since last year same period to 2.47 in the Q3 2025. This indicates that the Gilead Sciences Inc. has generated 22.28% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Gilead Sciences Inc. declared 0.79 dividend per share during the earnings announcement for Q3 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-07 | 2.16 | 2.47 | 14.35% |
2025-08-07 | 1.96 | 2.01 | 2.55% |
2025-05-07 | 1.77 | 1.81 | 2.11% |